HUE045731T2 - Mikro-RNS biomarkerek tüdõtumor diagnosztizálásához és/vagy kockázatának azonosításához - Google Patents

Mikro-RNS biomarkerek tüdõtumor diagnosztizálásához és/vagy kockázatának azonosításához

Info

Publication number
HUE045731T2
HUE045731T2 HUE12720568A HUE12720568A HUE045731T2 HU E045731 T2 HUE045731 T2 HU E045731T2 HU E12720568 A HUE12720568 A HU E12720568A HU E12720568 A HUE12720568 A HU E12720568A HU E045731 T2 HUE045731 T2 HU E045731T2
Authority
HU
Hungary
Prior art keywords
micro
diagnosing lung
lung tumour
rna biomarkers
identifying risk
Prior art date
Application number
HUE12720568A
Other languages
English (en)
Inventor
Gabriella Sozzi
Ugo Pastorino
Mattia Boeri
Original Assignee
Gabriella Sozzi
Mattia Boeri
Ugo Pastorino
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ITMI2011A000174A external-priority patent/IT1406866B1/it
Priority claimed from ITMI2011A000173A external-priority patent/IT1403685B1/it
Priority claimed from ITMI2011A000172A external-priority patent/IT1406672B1/it
Application filed by Gabriella Sozzi, Mattia Boeri, Ugo Pastorino filed Critical Gabriella Sozzi
Publication of HUE045731T2 publication Critical patent/HUE045731T2/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
HUE12720568A 2011-02-07 2012-02-07 Mikro-RNS biomarkerek tüdõtumor diagnosztizálásához és/vagy kockázatának azonosításához HUE045731T2 (hu)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
ITMI2011A000174A IT1406866B1 (it) 2011-02-07 2011-02-07 Procedimento ed apparecchiatura per identificare individui a rischio di tumore polmonare e/o per diagnosticare un tumore polmonare, nonché composizione e metodo per ridurre o eliminare il rischio di tumore polmonare
ITMI2011A000173A IT1403685B1 (it) 2011-02-07 2011-02-07 Procedimento ed apparecchiatura per identificare individui a rischio di tumore polmonare e/o per diagnosticare un tumore polmonare, nonche' composizione e metodo per ridurre o eliminare il rischio di tumore polmonare.
ITMI2011A000172A IT1406672B1 (it) 2011-02-07 2011-02-07 Procedimento ed apparecchiatura per identificare individui a rischio di tumore polmonare e/o per diagnosticare un tumore polmonare, nonche' composizione e metodo per ridurre o eliminare il rischio di tumore polmonare.
US201161522328P 2011-08-11 2011-08-11

Publications (1)

Publication Number Publication Date
HUE045731T2 true HUE045731T2 (hu) 2020-01-28

Family

ID=46062629

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE12720568A HUE045731T2 (hu) 2011-02-07 2012-02-07 Mikro-RNS biomarkerek tüdõtumor diagnosztizálásához és/vagy kockázatának azonosításához

Country Status (16)

Country Link
US (4) US20120225925A1 (hu)
EP (1) EP2734636B1 (hu)
AU (2) AU2012215105B2 (hu)
BR (1) BR112014003877A2 (hu)
CA (1) CA2844596A1 (hu)
CY (1) CY1121916T1 (hu)
DK (1) DK2734636T3 (hu)
ES (1) ES2742840T3 (hu)
HK (1) HK1197274A1 (hu)
HR (1) HRP20191481T1 (hu)
HU (1) HUE045731T2 (hu)
IL (1) IL230896B (hu)
PL (1) PL2734636T3 (hu)
PT (1) PT2734636T (hu)
RS (1) RS59161B1 (hu)
WO (1) WO2012107841A2 (hu)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012107841A2 (en) 2011-02-07 2012-08-16 Biomirna Holdings Ltd. Micro-rna biomarkers and methods of using same
US10011873B2 (en) 2012-11-16 2018-07-03 Universitat Des Saarlandes Diagnostic miRNA markers for Parkinson disease
EP2733219B1 (en) * 2012-11-16 2017-09-20 Siemens Aktiengesellschaft Diagnostic miRNA markers for Alzheimer
CN106164290A (zh) * 2014-01-05 2016-11-23 拜奥米尔纳控股有限公司 使用mirna比率确定肺癌
WO2015117205A1 (en) * 2014-02-06 2015-08-13 Immunexpress Pty Ltd Biomarker signature method, and apparatus and kits therefor
WO2016038119A1 (en) * 2014-09-09 2016-03-17 Istituto Europeo Di Oncologia S.R.L. Methods for lung cancer detection
WO2016049429A1 (en) * 2014-09-26 2016-03-31 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Microrna biomarkers for posttraumatic stress disorder and methods of use thereof
WO2016059241A2 (en) * 2014-10-17 2016-04-21 Biomirna Holdings Ltd. Lung cancer diagnostics and therapeutics with mir-660
TWI626314B (zh) * 2015-01-09 2018-06-11 長庚大學 評估罹患大腸直腸癌風險的方法
TWI571514B (zh) * 2015-01-09 2017-02-21 長庚大學 評估罹患大腸直腸癌風險的方法
US11535895B2 (en) 2017-04-06 2022-12-27 University Of Maryland, Baltimore Methods of detecting lung cancer

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2850323A1 (en) * 2004-11-12 2006-12-28 Asuragen, Inc. Methods and compositions involving mirna and mirna inhibitor molecules
US7943318B2 (en) * 2006-01-05 2011-05-17 The Ohio State University Research Foundation Microrna-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer
EP2487253B1 (en) * 2006-01-05 2015-06-24 The Ohio State University Research Foundation MicroRNA-based methods and compositions for the diagnosis and treatment of solid cancers
US8207325B2 (en) * 2006-04-03 2012-06-26 Univ. of Copenhagen MicroRNA biomarkers for human breast and lung cancer
US8361714B2 (en) * 2007-09-14 2013-01-29 Asuragen, Inc. Micrornas differentially expressed in cervical cancer and uses thereof
US20090186015A1 (en) * 2007-10-18 2009-07-23 Latham Gary J Micrornas differentially expressed in lung diseases and uses thereof
US20100323357A1 (en) 2007-11-30 2010-12-23 The Ohio State University Research Foundation MicroRNA Expression Profiling and Targeting in Peripheral Blood in Lung Cancer
US20110107440A1 (en) * 2008-06-04 2011-05-05 Andor Pivarcsi Skin cancer associated micrornas
EP2401405A4 (en) * 2009-02-26 2013-10-16 Univ Ohio State Res Found MICROARN IN NON-SMOKERS AND METHODS AND RELATED MATERIALS
EP2341145A1 (en) * 2009-12-30 2011-07-06 febit holding GmbH miRNA fingerprint in the diagnosis of diseases
EP2354246A1 (en) * 2010-02-05 2011-08-10 febit holding GmbH miRNA in the diagnosis of ovarian cancer
CN101804208A (zh) * 2010-02-26 2010-08-18 南京医科大学 miR-451在制备治疗非小细胞肺癌药物的应用
WO2012107841A2 (en) 2011-02-07 2012-08-16 Biomirna Holdings Ltd. Micro-rna biomarkers and methods of using same

Also Published As

Publication number Publication date
WO2012107841A3 (en) 2013-01-17
DK2734636T3 (da) 2019-08-26
AU2012215105B2 (en) 2017-05-11
EP2734636B1 (en) 2019-05-22
US20190062843A1 (en) 2019-02-28
IL230896B (en) 2019-10-31
ES2742840T3 (es) 2020-02-17
EP2734636A2 (en) 2014-05-28
CA2844596A1 (en) 2012-08-16
PT2734636T (pt) 2019-09-06
CY1121916T1 (el) 2020-10-14
US9926603B2 (en) 2018-03-27
AU2017213457B2 (en) 2019-08-29
HK1197274A1 (en) 2015-01-09
PL2734636T3 (pl) 2019-10-31
RS59161B1 (sr) 2019-10-31
HRP20191481T1 (hr) 2019-11-15
WO2012107841A2 (en) 2012-08-16
US20120225925A1 (en) 2012-09-06
US20150045233A1 (en) 2015-02-12
AU2017213457A1 (en) 2017-08-31
IL230896A0 (en) 2014-03-31
AU2012215105A1 (en) 2014-06-05
US20210130905A1 (en) 2021-05-06
BR112014003877A2 (pt) 2017-06-13

Similar Documents

Publication Publication Date Title
PT2734636T (pt) Biomarcadores micro-arn para identificar o risco de e/ou para diagnosticar tumor do pulmão
HK1247286A1 (zh) 使用分類系統和其成套設備識別及診斷肺部疾病的方法
IL252163A0 (en) Lung cancer biomarkers and their uses
HK1203091A1 (en) Methods for diagnosis of lung cancer
HK1193637A1 (en) Biomarkers for lung cancer
EP2569633A4 (en) COMPOSITIONS AND METHOD FOR IDENTIFYING TUMOR-SPECIFIC NEOANTIGENE
IL223295A0 (en) Lung cancer biomarkers and uses thereof
HK1204016A1 (en) Methods and kits for detecting subjects at risk of having cancer
EP2841603A4 (en) METHODS OF ASSESSING THE STATUS OF LUNG CANCER
EP2668295A4 (en) METHODS OF DETECTING LUNG CANCER
EP2748608A4 (en) LUNG CANCER TESTS
EP2633446A4 (en) IDENTIFICATION OF PHYSICAL LOCATIONS OF UNITS
EP2733490A4 (en) BIFUNCTIONAL TUMOR DIAGNOSIS REAGENT AND METHOD THEREFOR
HK1211345A1 (en) Methods of prognosis and diagnosis of cancer
ZA201501581B (en) Method of identifying media content
GB201600152D0 (en) Analysis of breathing data
SG11201402115TA (en) Methods for diagnosis and/or prognosis of gynecological cancer
GB2494580B (en) Method for diagnosing lung cancer
EP2521730A4 (en) GEN BIOMARKER FOR THE LUNG FUNCTION
EP2699699A4 (en) METHOD FOR THE DIAGNOSIS OF CANCER
EP2753716A4 (en) NEW RISK BIO MARKERS FOR LUNG CANCER
GB2510539B (en) Biomarkers of cancer
EP2732287A4 (en) METHOD FOR THE DIAGNOSIS OF CANCER
EP2728003A4 (en) METHOD FOR DIAGNOSING THE TYPE OF PANCREATIC TUMOR
GB201107118D0 (en) Method of diagnosis and prognosis